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ABSTRACT 
 The CDC estimated that seasonal influenza A virus (IAV) infections resulted in 
490,600 hospitalizations and 34,200 deaths in the US in the 2018-2019 season. The long-
term goal of our research is to understand how to improve innate immune responses to 
IAV. During IAV infection, neutrophils and macrophages initiate a respiratory burst 
response where reactive oxygen species (ROS) are generated to destroy the pathogen and 
recruit additional immune cells. While ROS molecules, such as hydrogen peroxide, help 
clear the virus, the signaling cascade can also lead to excess neutrophil recruitment, 
hyperinflammation, and tissue damage. Regulatory mechanisms that trigger over-
activation of neutrophils are not understood. We are developing a zebrafish (Danio rerio) 
transgenic fluorescent reporter line to study neutrophil function and hydrogen peroxide 
concentration during IAV infection in vivo. Using Tol2 transgenesis, we are developing 
this line to express the hydrogen peroxide biosensor protein, HyPer, specifically in 
neutrophils.  HyPer fluoresces at different wavelengths dependent on the concentration of 
hydrogen peroxide. We have designed the genetic construct to drive the expression of 
HyPer using the promoter of a gene highly expressed in neutrophils, myeloid peroxidase 
(mpx). Once developed, we plan to cross the line, named Tg(mpx:HyPer), to the neutrophil 
reporter line, Tg(mpx:GFP), and use offspring to visualize how neutrophils generate ROS 
in response to localized IAV infection. The Tg(mpx:HyPer);Tg(mpx:GFP) line may also 
be used to study neutrophil function and ROS in bacterial, fungal and other viral infections. 
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INTRODUCTION 
Threat to the Public health 
 The World Health Organization estimates that approximately 650,000 individuals 
die each year due to seasonal influenza A virus (IAV) infection. Influenza vaccines are 
used to help prevent infection, but are often not effective because there are many strains of 
the virus in the general population. Trivalent and tetravalent vaccines are altered every 
season based on influenza strains that are predicted to spread through the population 
(Yamayoshi 2019). Changes in influenza strains occur through antigenic shift and antigenic 
drift. Antigenic shift is the accumulation of mutations in the influenza genome that result 
in changes in surface antigens. Antigenic shift occurs when an antigen encoding sequence 
of two or more unique viruses are swapped, generating a novel virus with antigens from 
both particles. Antigenic shift may result in the development of more virulent viral particles 
with a higher fatality rate, while the antigens presented may not be designated targets of 
the present vaccine.  
New strains generated by antigenic shift are associated with influenza pandemics. 
There have been four pandemics in the last 100 years. The 1918 Influenza pandemic caused 
by a new H1N1 strain led to the deaths of approximately 50-100 million individuals 
worldwide (Yamayoshi 2019). The 1957-1958 Influenza pandemic was caused by a new 
H2N2 strain and led to 1.1 million deaths worldwide. The 1968 Influenza pandemic was 
caused by a new H3N2 strain and led to 1 million deaths worldwide. The 2009 Influenza 
pandemic was caused by H1N1 pdm09 and resulted in over 18,000 deaths (Watanabe 
2010). This virus was generated through the re-assortment of antigenic sequences between 
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a North American swine virus and Eurasian avian-like swine virus (Yamayoshi 2019). 
Influenza A Virus 
IAV is a negative sense single-stranded RNA (-ssRNA) virus classified as a 
member of the Orthomyxoviridae family (Dadonaite 2019, Dou 2018, Nayak 2013). The 
Orthomyxoviridae family of viruses that have between six and eight single-stranded 
negative sense RNA segments. The eight RNA segments in the IAV genome that is 
approximately 13,500 nucleotides in length contains a total of eleven viral genes. As the 
segmented genome is negatively sensed, the virus relies upon the host to transcribe the -
ssRNA to mRNA (+ssRNA) and then translate the mRNA to express viral proteins in order 
to replicate itself (Dadonaite 2019, Kwan, 2007, Watanabe 2010). Transcription and 
replication of the viral RNA occurs in the nucleus. The mRNA is exported from the nucleus 
to the cytoplasm where translation of the mRNA to protein occurs using host ribosomes 
(Dadonaite 2019). The eventual release of viral particles from the host cell is achieved 
through bud formation and scission of the plasma membrane (Dadonaite 2019, Pase 2012). 
While the majority of Influenza A virus particles are spherical in structure, some viral 
particles have been shown to be filamentous in nature (Dadonaite 2019). While we are 
primarily interested in the innate immune response to IAV, other types of Influenza viruses 
are Influenza B and C that are both within the Orthomyxoviridae family. The genome of 
Influenza B, like IAV, contains eight RNA segments, while Influenza C contains seven 
segments (Dadonaite 2019).  
Within the lipid bilayer envelope of IAV, there are three transmembrane proteins 
(Dadonaite, 2019). The largest proportion of surface proteins expressed is Hemagglutinin 
which comprises of approximately 80% of the proteins on the viral envelope (Dadonaite 
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2019). The role of the 18 known Hemagglutinin variants is to interfere with the successful 
utilization of host produced antibodies, protecting the viral particle from immune response, 
as well as binding to the host cell plasma membrane (Dadonaite 2019). The second most 
abundant envelope protein in IAV is Neuraminidase, which has a total of 11 variants and 
totals approximately 17% of the transmembrane proteins. Neuraminidase binds and cleaves 
sialic acid receptors which is expressed on the exterior of host cell plasma membranes 
enabling the virus particle to enter the cell (Dadonaite 2019). Influenza virus subtypes are 
named based on the combination of hemagglutinin and neuraminidase antigens expressed. 
For example, the H1N1 subtype is hemagglutinin 1 and neuraminidase 1. The third 
transmembrane protein is a M2 ion channel that aids in the virus budding and scission 
during viral release (Figure 1) (Dadonaite 2019).  
 
 
Figure 1: The viral structure of Influenza A virus. Image Adapted from: Textbook of Influenza, Second 
Edition. Edited by Robert G. et. al.  2013 
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Immunity 
The immune system of an organism can be subdivided into the innate and adaptive 
immunity. Adaptive immunity is developed following initial exposure to antigen that 
allows for a more efficient immune response if the organism is exposed to that antigen in 
the future (Punt 2019). Adaptive immunity is the basis by which vaccines work. A vaccine 
exposes the immune system to an antigen in the form of an inert particle or protein from a 
pathogen prior to exposure with a live pathogen (Punt 2019). While the adaptive immune 
system provides a robust response to a pathogen, innate immunity provides both a defense 
to infection and response to injury. The innate immune system is comprised of multiple 
cell types include phagocytes and other cells that function as epithelial barriers to ward off 
pathogen entry. Phagocytes, such as neutrophils and macrophages, release chemicals used 
to destroy and engulf foreign particles (Punt 2019). These phagocytes develop from a 
common myeloid progenitor found in bone marrow (Punt 2019). 
 Following infection by a pathogen, cytokines are released into the circulatory 
system to signal the presence of damage and/or foreign particles. Cytokines, such as TNFa, 
and IL-1b, promote an inflammatory response and recruit immune cells through 
chemotaxis (Punt 2019). Vasoactive factors released near the site of infection increases 
local blood flow, and capillary permeability to allow leukocytes to migrate to the site of 
infection (Pase 2012, Punt 2019). The majority of immune cells that migrate to the site of 
infection are macrophages and neutrophils to clear the infection. Both cell types are capable 
of producing an oxidative burst, where reactive oxygen species are released to destroy 
phagocytosed particles, and act as a cell signaling particle (Pase 2012, Punt 2019, Yoo 
2011). 
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Inflammatory response 
The response by the innate immune system to infection and/or injury is a dynamic 
process where signaling cascades control the expression of genes. Reactive oxygen species 
(ROS) is an important signaling molecule durring an inflammatory response (Punt 2019, 
Panday 2015, Niethammer 2009). ROS molecules and ther intermediates, such as hydrogen 
peroxide (H2O2) and hypochlorite, also function to degrade deceased cells, pathogens, and 
foreign particles (Pase 2012, Punt 2019). However, these molecules do not discriminate 
between their designated targets and the surrounding tissue of the organisum (Punt 2019). 
ROS can cause damage to the surrounding tissues. As such, the processes relating to ROS 
containing molecules must be tightly regulated to enable an effective response without 
negatively impacting the health of the organisum (Pase 2012).  
 ROS are generated in cells by the NADPH oxidase (NOX) complex (Figure 2) 
(Punt 2019, Panday 2015). In the zebrafish, the primary protein in this NOX complex is 
cybb. The cytosolic subunit of the NOX complex, named P47, is encoded by the neutrophil 
cytosolic factor 1 (ncf1). P47 is an important activator of the NOX complex. Once the 
complex is activated, it is translocated to the membrane (Panday 2015). Another regulator 
of ROS is nfe212a, a transcription factor used to regulate the transcription of antioxidant 
proteins that protect tissues from damage. Expression of the serpina1 gene is regulated by 
nfe2l2a transcription factor, and functions to reduce damage to surrounding tissues from 
inflammatory enzymes. The expression of superoxide dismutase 1 (sod1) is also regulated 
by nfe2l2a, and is used to render superoxide inert. All of these genes function as part of the 
dynamic response to pathogen infection. 
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Figure 2: The NADPH oxidase complex generates radical oxygen molecules to develop reactive oxygen 
species containing molecules for use in the respiratory burst response. Image adapted from Gonzalez-Perilli 
L et al. (2019). 
 
 If the oxidative burst is not carefully regulated, a hyperinflammation may occur. 
Hyperinflammation occurs when ROS generated by the response to infection recruit and 
activate additional phagocytes to the site of infection. It is known that the signaling from 
ROS particles recruit additional neutrophils to the site of infection (Yoo 2011). The 
additional neutrophils further promote an oxidative burst cascade. We believe that a 
hyperinflammatory response to an influenza A virus infection correlates with neutrophil 
density and the activity of the respiratory burst response.    
 
Transgenic Zebrafish Models 
 The zebrafish is useful vertebrate model to study the mechanisms of human disease 
in vivo. Zebrafish can be easily grown on larger scales and less expensively than 
mammalian models allowing for larger sample sizes (Yoo 2011). Zebrafish embryos are 
cybb encoded  
ncf1 encoded 
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transparent for up to five days post fertilization and enables in vivo observations using 
microscopy (Yoo 2011). Zebrafish embryos develop ex utero, and can be collected at single 
cell stage. At the single cell stage, a microinjection can be used to make a transgenic 
zebrafish line by injecting a plasmid, or a morphant by injecting an antisense morpholino. 
Transgenic zebrafish lines are used to model diseases in several ways. One example is the 
WHIM (Tg1(-8mpx:cxcr4b-EGFP) model that overexpresses a transgene that has a 
truncated cxcr4b gene that impairs neutrophil function. Another example are fluorescent 
reporter lines that can be used to visualize individual cell types in vivo using fluorescent 
reporter molecules like green fluorescent protein (GFP) (Pase 2012) (Figure 3). Fluorescent 
reporter zebrafish lines used study neutrophil migration include the Tg(mpx:GFP) and 
Tg(mpx:Dendra2) zebrafish lines (Yoo 2011). To expand available zebrafish models of 
innate immune responses, this project sought to generate a zebrafish line in which 
neutrophils express a ROS biosensor.  
 
 
Figure 3: Transgenic zebrafish model Tg(MPO:mCherry), with MA-eCFP-PR8 color-flu injected into 
swimbladder. The neutrophils are shown in green, and the IAV fluoresces blue.  
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The HyPer protein was engineered to be a ROS biosensor, with fluorescence 
activity dependent on the concentration of ROS molecules (Panday 2015). This protein was 
developed by inserting the a circularly permuted yellow fluorescent protein (YFP) into the 
E. coli OxyR H2O2 sensing protein (Belousov 2006). Following oxidation of Cry199 from 
hydrogen peroxide, Cry199 and Cry208 form a disulfide bond resulting in conformational 
changes in OxyR residues 205-222 (Figure 4) (Belousov 2006) As OxyR is a prokaryotic 
protein, there should be no interactions with intracellular signaling in eukaryotic cells 
(Belousov 2006). The presence of this protein product in locally damaged tissue, or near 
the site of infection allow for the detection of H2O2 (Panday 2015). H2O2 is predominantly 
produced by neutrophils and other granulocytes. The Tg(lyz:Hyper) model use the 
Lysozyme C (lysc) promotor to express HyPer in neutrophils allowing visualization of the 
H2O2 concentration at a wound site (Panday 2015, Pase 2012) (Figure 5). 
 
 
Figure 4: Scheme of HyPer oxidation resulting from hydrogen peroxide exposure. Residues Cys199 and 
Cys208 of the OxyR protein generate a disulfide bond resulting in conformational changes of the regulatory 
domain of OxyR. Figure developed with information provided in Belousov 2006, Bilan 2018. 
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Figure 5: Neutrophils of the Tg(lyz:HyPer) zebrafish model migrate to wound site following amputation of 
fin. Image taken 59.5 minutes post amputation. The detected fluorescence transitions from blue to yellow in 
the presence of hydrogen peroxide. The Neutrophil denoted in the white circle shows the transition from 
green to yellow indicating an increasing concentration of hydrogen peroxide. Image adapted from Pase 2012. 
 
  
Multisite Gateway Cloning is used to generate complex plasmid vectors for use in 
transgenesis that are constructed using multiple entry vectors. The LR Clonase reaction 
using the att site recombination system of lambda phage (Kwan 2007). Using attR and attL 
sequences in the entry vectors, the vectors are cloned into the destination vector is a 
designated order. The 5p entry clone contains the promotor element of interest with 
flanking attL4/R1 sites (Kwan 2007). The middle entry vector contains the coding sequence 
of interest, e.g. the coding sequence of a reporter like HyPer, flanked by attL1/L2 
sequences. The 3p entry vector most often contains a polyadenylation (polyA) signal 
(Kwan 2007). The final plasmid vector is coinjected into a single cell zebrafish embryo 
with Tol2 transposase RNA to generate founders of a transgenic line (Figure 7). The 
multisite Gateway Cloning system has successfully used in zebrafish to make several 
zebrafish lines (Kawakami 2007).  
Neutrophils  
Fin Amputation Plane 
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Figure 6: Multisite Gateway Cloning. Scheme of LR reaction of three entry vectors using LR Clonase I.   
 
 
 
Figure 7: Coinjection of final mpx:HyPer plasmid and Tol2 transposase RNA. Image adapted from 
Kawakami, 2007. 
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The long-term goal of this project was to create a transgenic zebrafish line that 
would express HyPer specifically in neutrophils. In multisite Gateway Cloning, expression 
of the reporter gene is driven by a promoter for a gene that is specific to the cell type of 
interest. In several zebrafish neutrophil reporter lines, the promotor for myeloid-specific 
peroxidase (mpx) was used (Yoo 2011). This enzyme is expressed in neutrophils, and plays 
a role in the formation of reactive oxygen intermediates (Yoo 2011). A 5p entry clone 
containing the mpx promotor was Jeremy Charette, a former graduate student in Prof. Carol 
Kim’s Lab at the University of Maine. The HyPer coding sequence used was obtained from 
a actb:HyPer plasmid given to Prof. King’s Lab by Prof. Philipp Niethammer at Memorial 
Sloan Kettering Cancer Center (Niethammer 2009). This plasmid contained a promotor for 
beta actin, a gene expressed in most cell types, followed by the HyPer sequence. Following 
PCR amplification, we worked to clone that HyPer coding sequence into pME-MCS using 
a BP Clonase II reaction.  
Using a LR reaction, the final plasmid vector would be assembled using the 5p-
entry, middle-entry, and 3p-entry clone into the destination vector, pDestTol2pACryGFP 
(Berger 2013). This destination vector contains an alpha-crystallin promotor preceding a 
GFP sequence to enable screening of zebrafish at 2 days post fertilization to detect 
successful transgenesis. The 5p entry vector, p5E-mpx, contains the mpx promotor. The 
middle entry vector, pME-HyPer, would contain the HyPer coding sequence successfully 
cloned into pME-MCS. The third plasmid to be used in the final vector assembly was p3E-
polyA. Following the successful cloning of HyPer into the middle entry vector, the three 
sequences would have been combined in the Tol2 plasmid destination vector, to generate 
the mpx:HyPer plasmid. 
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 The Tg(mpx:HyPer) model we worked towards generating would be useful to 
characterize concentrations of H2O2 in neutrophils in vivo following infection or injury. 
This would be a powerful tool to further understand innate immunity and inflammatory 
responses to infection (Yoo 2011). This model would also help us understand 
hyperinflammatory responses. These responses can lead to tissue damage following excess 
neutrophil recruitment and ROS production. The model, Tg(mpx:HyPer), would enable us 
to use fluorescent microscopy to observe both events. 
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METHODS 
Re-suspending plasmids in dH2O 
 Plasmids from the Tol2 kit were resuspended in molecular grade DNAse/RNAse 
free water. The lab workbench was sprayed with ethanol prior to removal of plasmids from 
Tol2 kit packaging. Scissors were sprayed with ethanol prior to excising the plasmid 
containing filter paper for each plasmid. Sterile forceps were used to place each excised 
filter paper into 1.5 ml microcentrifuge tubes that were pre-labeled. When resuspending 
the plasmid, 50 μL of DNAse/RNAse free water was added to the tube.  
 
Bacterial Transformations 
 Tubes containing plasmid and 10-beta competent E. coli (New England Biolabs, 
Ipswich, MA) were defrosted on ice. Once defrosted, 1μl of plasmid was added to the 
bacteria. Solution was lightly mixed and incubated for 30 minutes on ice. The bacteria 
solution warmed to 42°C for 30 seconds and incubated for 5 minutes on ice. Following 
incubation, 925 μl of 10-Beta/Stable Outgrowth Media (New England Biolabs, Ipswich, 
MA) was warmed to 37 °C added to solution. Bacterial solution was incubated at 37°C for 
60-75 minutes on a shaking incubator set at 225 rpm.  
 
Plating Bacteria: 
 To generate 9 plates to culture the bacteria, 3.75 g of agar and 6.25 g of Luria 
Broth (LB) was added to 250 ml of dH2O. The solution was then autoclaved. While agar 
solution was cooling on a stir plate, 125 μl of 1000X antibiotic stock (Ampicillin or 
Kanamycin) was added. The plates are then poured, and cooled in a 37°C incubator. 
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Following the final incubation in the transformation protocol, bacteria were plated. 
Bacteria were plated with differing volumes ranging from 50 μl, 100 μl, 150 μl using a 
sterile cell spreader. The plates with are incubated overnight at 37°C, while unused plates 
are stored in a 4°C refrigerator.  
 
Overnight liquid cultures: 
 For each colony of interest that grew on a plate, 7 ml of LB media was added to 
sterile glass tubes. 3.5 μl of antibiotic stock was added to each tube, and lightly mixed by 
vortexing. Volumes of Kanamycin and/or Ampicillin stock may vary depending on 
previously noted bacterial survival. A single sterile loop was used to transfer the bacterial 
colony from a plate to the appropriately labeled liquid culture. The liquid cultures were 
incubated at 37°C overnight on a shaking incubator set at 180 rpm.   
 
Plasmid Isolation using QIAprep Spin Miniprep Kit: 
 Following an overnight incubation period, 500 μl of liquid culture was combined 
with a glycerol solution in a freezer tube generating a glycerol stock. 1.4 ml of liquid culture 
was centrifuged at 2 rcf (relative centrifugal field) for 3 minutes at 18°C. The supernatant 
was discarded in a bleach solution. This process was repeated until the entirety of the liquid 
culture was pelleted. The pellet of bacteria was resuspended in 250 μl of P1 Buffer. 250 μl 
of LyseBlue lysis reagent and Buffer P2, was added to the microcentrifuge tube. The 
solutions were mixed through 4-6 inversions of the tube. Following an incubation at room 
temperature for 5 minutes, 350 μl of Buffer N3 was added to the sample and was mixed 
via inversions 4-6 times until the solution became clear. The sample was centrifuged for 
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10 minutes at 10,000 rpm. 800 μl of the resulting supernatant was added to a QIAprep 2.0 
spin column. Flow-through following a 60 second centrifugation was discarded. The 
column was washed for 60 seconds at 13,000 rpm with 500 μl of BufferPB, and the 
supernatant was discarded. The column was washed for 60 seconds at 13,000 rpm with 750 
μl of BufferPE, and the supernatant was discarded. The column was dried by an additional 
60 second 13,000 rpm centrifugation. The column was placed in a 1.5 ml microcentrifuge 
tube. DNA was eluted with 30μl of DNAse/RNAse free water. Plasmid concentration and 
purity was evaluated using a NanoDrop OneC spectrophotometer (Thermo Scientific 
Fisher, Waltham, MA).  
 
PCR amplification of the HyPer sequence: 
 PCR amplification of HyPer was performed using New England Biolabs (NEB) Q5 
High-Fidelity DNA Polymerase following the manufacturer’s protocol (Table 1.) The 
primers used were designed to amplify a HyPer sequence containing restriction sites to be 
used in restriction digests enabling the development of pME-HyPer from a BP Clonase II 
reaction (Figure 8). When the ligation of the BP reaction yielded poor results, primers were 
redesigned with the attB1, and attB2 sites (Table 2.). The PCR protocol used 35 cycles for 
DNA amplification, using the temperatures recommended from NEB (Figure 9).  
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Table 1. The Reagents used for a 50μl PCR reaction to amplify HyPer. 
Reagent(s)  Volume (50μl reaction) 
5X Q5 Reaction Buffer 10μl 
10 mM dNTPs 1μl 
10 μM Primers (F +R) 5μl 
Template DNA Final concentration <1,000ng 
5X Q5 High GC Enhancer  10μl 
Q5 High-Fidelity DNA Polymerase 0.5μl 
Nuclease Free Water Volume to 50μl 
 
 
Figure 8: The forward and reverse primers for the HyPer sequence. The CACC highlighted in the blue box 
is the Kozak sequence. The BamH1 restriction site is highlighted in the yellow box, and the EcoR1 restriction 
site is in the purple box. The sequences highlighted in the green box are complementary to the HyPer coding 
sequence.  
 
Table 2. Primer sequences of attB1/attB2 sites.  
attB1/attB2 Primer Sequence(s) 
Forward 5’ – TCAAGTTTGTACAAAAAAGCAGGCTCGATGGAGATGG 
        CAAGCCAGCAG – 3’  
Reverse 3’ – CCCCACTTTGTACAAGAAAGCTGGGTGTTAAACCGCCTGT – 3’  
 
 
Figure 9: HyPer PCR amplification protocol used with NEB Q5 Polymerase.  
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Fast Digestion of DNA: 
 To digest the unpurified HyPer PCR product, a Fast digestion protocol from 
Thermo Fisher Scientific was used. A 30 μl reaction was set up using 2 μl of 10X 
FastDigest buffer, approximately 2 μg of DNA, 0.5 μl of EcoR1, 0.5 μl of BamH1, and 25 
μl nuclease free water to total volume. This solution was incubated at 37°C for 30 minutes. 
The enzymes were inactivated at 65°C for 20 seconds.  
 
Ligation of pME-MCS and HyPer: 
 To ligate the HyPer plasmid fragment in a 100 ng reaction, 2 μl of pME-MCS 
plasmid was added into a 1.5 ml microcentrifuge tube. 2 μl of T4 ligation buffer was added 
to the tube. HyPer digestion was added to the microcentrifuge tube with variable volumes 
to achieve a final concentration of 50 ng/μl. Molecular grade water was applied to bring 
the total volume to 19 μl. T4 ligase was added to the tube with a volume of 1 μl. The sample 
was incubated overnight at 4°C 
 
qRT-PCR of Genes Related to Oxidative Burst 
 If needed, oligos were re-suspend to a 100 μM concentration for each of the genes 
being evaluated. For each pair of oligos, 5 μl of the forward and reverse oligos were mixed 
with 90μl of nuclease free water in a 1.5 ml microcentrifuge tube (Table 3). Bio-Rad 
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, Hercules, CA), nuclease free 
water and oligo solution was generated (Table 4). To each appropriate well on a Bio-Rad 
qPCR plate, 9 μl of master mix was added. To each appropriate well, 1 μl of the sample 
cDNA was added to the well. The plate was covered with a Bio-Rad plate adhesive film. 
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The sealed plate was vortexed lightly to mix the master mix and cDNA. The plate was 
placed in the Bio-Rad CFX96 plate, and the software of the qRT-PCR program was run to 
determine threshold cycle (Ct) values for each sample. Fold changes were calculated using 
the DDCt method. 
 
Table 3: The Oligos used for qRT-PCR to evaluate genes related to the Oxidative Burst 
qRT-PCR Oligos 
 
Gene 
Symbol Sequence Forward Sequence Reverse 
serpina1 AAGCTCTGTGGACCTGTTTATG  CATGGTGCTGTCCTCTACAATC  
sod1 CTCTGTCAGGCCAACATTCTAT  GTAATTGTCAGCGGGCTAAGT  
actb GATCTGGCATCACACCTTCTAC  CACCAGAGTCCATCACAATACC  
nfe2l2a TGTCCTTCCTCCTTCTCTCTT  CGTCGATGTTTATTGCCTCTTTAC  
ncf1 CAGCTCATTCGGGACTTCTT GTTCTCTCTGTTTGTCCTCCTC 
cybb CCTGGGAGGACTTTCACTTTC CTTGTGCTGTCTGCCTAGTT 
 
Table 4: Master mix for each gene of interest composition and reagent volumes made for (Y-1) reactions.  
Reagent Volume Example (Y=7) 
SYBR Green 5μl x Y 5μl x 7 = 35μl 
Nuclease-free water 3.5μl x Y 3.5μl x 7 = 24.5μl  
Forward + Reverse oligos 0.5μl x Y 0.5μl x 7 = 3.5μl 
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RESULTS 
Design of a Tol2-compatable plasmid to express a neutrophil-specific reactive oxygen 
species biosensor in zebrafish. 
 A Tol2-compatable expression plasmid was designed to generate a stable transgenic 
zebrafish line to express HyPer specifically in neutrophils. The overall plasmid design was 
based on multisite Gateway cloning that assembles three entry clones and a Tol2-based 
destination vector. The three entry clones assemble into a construct that includes a 
promoter sequence to initiate transcription in the cells of interest, coding sequence of the 
reporter protein, and poly-adenylated (polyA) tail for transcription termination. In Gateway 
cloning technology, the three entry clones are named the 5p entry (p5E), middle-entry 
(pME), and 3p-entry (p3E) clones, respectively. For this design, the p5E clone included 
the promoter for the myeloid peroxidase (mpx) gene, a gene that is highly expressed in 
neutrophils. This clone was named p5E-mpx. The pME clone was designed to contain the 
coding sequence for HyPer. This clone was named pME-HyPer. The p3E clone contained 
the polyA tail and named p3E-polyA. The destination vector used in our design, named 
pDestTol2pACryGFP, expresses GFP using an alpha-crystallin promoter that can be used 
to screen transgenic embryos by lens florescence. The following sections describe the three 
entry clones, destination vector, and the final plasmid design in more detail. 
 
5p entry clone containing the mpx promoter (p5E-mpx) 
 In order to develop the transgenic line, a 5p entry clone that contained the mpx 
promoter in order to drive expression of HyPer specifically in neutrophils was used. This 
p5E-mpx clone was created by Jeremy Charette, a former graduate student in Prof. Carol 
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Kim’s Laboratory at the University of Maine. Colonies of this clone were grown with 10B- 
E. coli and a portion of the mpx promoter from the clone was sequenced. The sequence 
contained the first intron that was 345 bp long, the first exon that was 135 bp long, and 353 
bp upstream of the first exon (Figure 10). This sequence was only a portion of the mpx 
promoter in the p5E-mpx clone and additional sequencing needs to be performed to 
completely verify the promoter in the p5E-mpx clone. This sequence also matched a 
portion of the mpx promoter that was used in the Tg(mpx:EGFP) zebrafish neutrophil 
fluorescent reporter line developed by Prof. Anna Huttenlocher’s Laboratory at the 
University of Wisconsin (Freisnger 2014). In this line, the mpx promoter drives the 
expression of enhanced green florescent protein (EGFP) in neutrophils and is used by our 
laboratory and others worldwide to visualize neutrophils in embryos using confocal 
imaging (Figure 3). The Tg(mpx:EGFP) line uses a mpx promoter that is 8,177 bp in length 
(Figure 11). The mpx promoter sequence was derived by taking 10,000 bp upstream of mpx 
in the GRCz11 zebrafish genome assembly and looking for the fragment between the ChoI 
and XhoI restriction enzyme cut sites described in Prof. Huttenlocher’s paper. This 
promoter sequence contained the first exon, the first intron, and 7,082 bp upstream of the 
first exon. However, the sequence did not align adjacent to the beginning of the second 
exon as the p5E-mpx clone sequence did (Figure 12). Since a complete sequence for the 
p5E-mpx clone was not generated, the p5E-mpx clone sequence was merged with the 7,092 
bp sequence. The resulting sequence was used as the mpx promoter sequence in the p5E-
mpx clone for the purposes of designing the mpx:HyPer plasmid. Using the predicted mpx 
promoter sequence, we made a sequence map for the 8,341 bp p5E-mpx clone that will be 
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used as the 5p entry vector to develop the Tg(mpx:HyPer) transgenic zebrafish line (Figure 
13). 
 
Figure 10: Pairwise BLASTN alignment of a 1,144 bp sequence of a fragment of the p5E-mpx clone and 
Chr. 10 from the GRCz11 zebrafish assembly. The coordinates of exon 1 for mpx are from Chr. 10: 
7,785,885-7,786,020 in reverse orientation (highlighted in blue). The alignment was 96% identical over 844 
bp. 
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Figure 11: Restriction enzyme map of 10,000 bp region upstream of mpx in the GRCz11 zebrafish genome 
assembly. The Tg(mpx:EGFP) reporter line used an 8,177 bp region between the ClaI and XhoI restriction 
enzymes (highlighted in blue). 
 
 
 
Figure 12: Alignment of the p5E-mpx clone and Huttenlocher mpx promoter sequence to the GRCz11 
zebrafish genome assembly viewed in the UCSC Genome Browser. The p5E-mpx clone sequence aligns up 
to the start of the second exon. The two sequences were merged to generate a predicted promoter sequence 
from Chr. 10:7,785,544-7,793,885 that was 8,341 bp in length. 
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Figure 13: Circularized map of the predicted sequence of the p5E-mpx plasmid. This plasmid was 
developed by Jeremy Charette, of the Kim lab at the University of Maine. The predicted plasmid contains a 
total of 11,010 nucleotides, and contains the functional mpx promotor. 
 
Middle entry clone containing the HyPer coding sequence (pME-HyPer) 
 The next step to create the Tg(mpx:HyPer) line was to generate a middle entry clone 
that containing the coding sequence (CDS) of reactive oxygen species biosensor, HyPer. 
The strategy was to insert the HyPer CDS into the pME-MCS donor plasmid using a BP 
Clonase II reaction. The BP Clonase II enzyme recombines PCR products that have attB 
sites and a donor vector that contains attP sites to generate an entry clone. The King Lab 
acquired a actb:HyPer plasmid from the Philipp Niethammer at Memorial Sloan Kettering 
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Cancer Center (Figure 14) (Enyedi 2013). Within the actb:HyPer plasmid, the HyPer 
coding sequence is located between attB1 and attB2 sites. The pME-MCS donor plasmid 
contained the attP sites.  
The HyPer CDS from the actb:HyPer plasmid was amplified using PCR and a 
fragment of the PCR product was sequenced (Figure 15).  The sequence of the product was 
identical to the sequence provided by the Niethammer Lab. We were unsuccessful in 
generating a pME-HyPer plasmid using a BP Clonase II reaction. However, we did create 
a sequence to represent the pME-HyPer plasmid (Figure 16). This sequence was created 
by editing the sequence of the pME-EGFP clone from the Tol2kit and replacing the EGFP 
CDS with the HyPer CDS.  
 
 
Figure 14: Circularized map of the actb:HyPer plasmid. The 13,128 bp plasmid sequence was provided 
by the Niethammer Lab. HyPer sequence shown to be properly located between attB1 and attB2 sites. 
Ampicillin resistance gene with associated promotor is located on right arm of plasmid. 
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Figure 15: Pairwise BLASTN alignment of a 1,121 nucleotide sequence of the PCR amplified 
LR(actb:HyPer) plasmid sequence provided by the Niethammer Lab. The coordinates for the HyPer sequence 
in the plasmid are 5,348-6,784 (indicated in blue). The alignment was 97% identical over 1,084 bp. 
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Figure 16: Circularized map of the predicted sequence of the pME-HyPer plasmid. This 4,046 bp 
sequence was generated by substituting the EGFP coding sequence with the HyPer coding sequence from the 
Niethammer actb:HyPer plasmid shown in Figure 14. 
 
3p entry clone containing a polyA sequence (p3E-polyA) 
 The 3p-entry clone that was to be used in the final vector assembly by LR Clonase 
reaction was the p3E-polyA sequence provided in the Tol2Kit (Figure 17). Clones of this 
plasmid were cultured under the selective pressure of the antibiotic kanamycin. In the final 
vector assembly, this entry clone contains a polyA sequence that is required for HyPer 
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expression. A polyA sequence was engineered in the actb:HyPer plasmid from the 
Niethammer Lab (see Figure 14). 
 
 
Figure 17: Circularized plasmid map of 3’ entry vector used in final vector assembly. This 2838 
nucleotide 3’ entry vector contains a SV40 polyA sequence.  This p3E-polyA plasmid was provided in the 
Tol2 kit.  
 
Destination vector (pDestTol2pACryGFP) 
 The destination vector planned that was to be used in the generation of the final 
vector assembly was pDestTol2pACry (Figure 18) (Berger 2013). This plasmid was 
obtained from AddGene. This plasmid was designed to express GFP in the lens of zebrafish 
using an alpha-crystallin (cryaa) promotor. Expression of GFP in the lens will allow for 
rapid screening of embryos that express the mpx:HyPer transgene. 
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Figure 18: Circularized plasmid map of the pDestTol2pACryGFP destination vector. This destination 
vector was obtained from AddGene and is utilized for final vector assembly and screening transgenic 
zebrafish. Within this plasmid, there is a GFP encoding sequence following an cryaa promotor.  
 
Predicted plasmid design 
 The final vector assembly would be generated using the 5p, 3p, and middle entry 
vectors with the destination vector. This vector would be assembled through an LR Clonase 
reaction of the four components. Ideally this vector would be assembled in the proper 
orientation with the 5p entry vector containing the mpx promotor ahead of the HyPer 
coding sequence provided in the pME-HyPer sequence followed by the poly A sequence 
of the 3p entry vector. Using the A Plasmid Editor (ApE) software, we generated a 
predicted final vector sequence from the LR reaction (Figure 19).  
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Figure 19: Predicted final plasmid sequence. Using the ApE software, a   using the p5E-mpx, pME-HyPer, 
p3E-polyA, and Tol2 destination vector, pDestTol2pACryGFP using LR Clonase. The plasmid is expected 
to contain the 8.3kb mpx promotor, 1.5kb HyPer coding sequence and an Ampicillin resistance gene.  
 
Expression of innate immune system genes associated with ROS 
 The response of the innate immune system to infection and/or injury is a dynamic 
process that involves the regulation of gene expression. The expression of a total of five 
genes in 48 hpf embryos injected with HBSS or IAV at time points ranging from 0 to 120 
hours post infection (hpi) was assayed by qRT-PCR. NADPH oxidase 2 (cybb) was 
significantly upregulated at 18, 24, and 96 hpi (Figure 20A). Neutrophil cytosolic factor 1 
(ncf1) was significantly upregulated at 12, and 36 hpi, and significantly downregulated at 
18 hpi (Figure 20B). Nuclear factor erythroid 2-related factor 2 (nfe2l2a) was significantly 
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downregulated at 12 and 72 hpi, and significantly upregulated at 24, and 120 hpi (Figure 
20C). The expression of alpha-1 antitrypsin (serpina1) was significantly increased at 18 
hpi (Figure 20D). Superoxide dismutase 1 (sod1) was significantly downregulated at 3 and 
6 hpi (Figure 20E). 
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Figure 20: Expression of cybb, ncf1, nfe2l2a, serpina1, and sod1 during IAV infection from 0-120 hpi. 
Log2 fold change of candidate genes at 0, 3, 6, 12, 18, 24, 36, 48, 60, 72, 96, and 120 hpi (n = 3) comparing 
HBSS injected and IAV infected 48 hpf zebrafish embryos. The expression of beta-actin (actb) was used to 
normalize gene expression levels in all samples. (A) The expression of cybb was significantly upregulated 
at 18, 24, and 96 hpi. (B) The expression of ncf1 was upregulated at 12, downregulated at 18 hpi, and 
upregulated again at 36 hpi. (C) The expression of nfe2l2a was downregulated at 12 hpi, upregulated at 24 
hpi, downregulated at 72 hpi, and upregulated at 120 hpi. (D) The expression of serpina1 was upregulated 
at 18 hpi. (E) The expression of sod1 was downregulated at 3, and 6 hpi. 
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DISCUSSION 
Development of the Transgenic Zebrafish Model: 
 The long term goal of this project was to develop a new transgenic zebrafish 
fluorescent reporter line, Tg(mpx:HyPer), to visualize ROS generated by neutrophils. This 
model would express the HyPer protein, a ROS biosensor, specifically in neutrophils. This 
biosensor fluoresces at differential wavelengths dependent on the concentration of ROS. 
This model could be used to study the inflammatory response to viral, bacterial, or fungal 
infection, or with injury.  
 Founders for the transgenic line would have been created by coinjection of the final 
plasmid vector and the Tol2 transposase into fertilized zebrafish embryos. The final vector 
would have been generated using multisite Gateway cloning where a LR Clonase reaction 
would assemble the three entry vectors and a singular destination vector. Prior to the final 
vector assembly, the middle entry clone, pME-HyPer, would need to be generated using a 
BP Clonase reaction. The final plasmid vector that was designed was approximately 15.9kb 
in length (Figure 19). Following microinjections, visual screening of potential transgenic 
positive zebrafish would occur at 2 dpf by observing GPF expression in the eyes of 
embryos. Once these transgenic embryos develop into adult zebrafish, these founders are 
bred to create a stable transgenic line after multiple generations. Embryos from these adults 
can be used to study ROS generated by neutrophils in the context of infection or injury. 
 The design of the Tg(mpx:HyPer) transgenic line uses the promoter for mpx to drive 
expression of HyPer in neutrophils. We don’t know if mpx is the most efficient promoter 
by which to express HyPer in neutrophils. Lysozyme C (lysc) is another gene that is highly 
expressed in neutrophils. Using the promotor for lysc is another potential way to drive the 
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expression of HyPer in neutrophils (Figure 5). It may turn out using a lysc promotor may 
prove to be more efficient. The overall process of designing a Tg(lysc:HyPer) transgenic 
line would the same, but a different entry clone (p5E-lysc) would need to be developed and 
used in the multisite LR Clonase reaction.   
 
Development of the pME-HyPer entry clone from the BP reaction: 
 This project was stalled during the development of the pME-HyPer entry clone. 
This plasmid was to be generated through a BP Clonase II reaction where the HyPer 
sequence from the Sloan-Kettering plasmid would have been cloned into the pME-MCS 
plasmid from the Tol2 kit. We believe that the BP reaction did not work due to the primers 
used to amplify the HyPer coding sequence that was flanked by the attB sites. We made 
several attempts to complete the BP reaction, but the product of those reactions did not 
resemble the expected plasmid entry vector shown in Figure 16. A different primer design 
should make it possible to create the correct pME-HyPer plasmid. 
 
Differential Gene Expression in Response to Infection: 
 Using qRT-PCR we evaluated the differential expression of five genes known to 
be associated with the respiratory burst response. NADPH oxidase 2 (Cybb) is the primary 
protein that is responsible for the generation of reactive oxygen species. (Figure 2). 
Neutrophil cytosolic factor 1 (ncf1) encodes the p47 protein which is a part of the Nox2 
complex, regulating neutrophil activity. Nuclear factor erythroid 2-related factor 2 
(nfe2l2a) encodes a transcription factor used to regulate the transcription of antioxidant 
proteins which protect tissues from damage. Alpha-1 antitrypsin (serpina1) transcription 
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is regulated by Nfe2l2a, and plays a role in preventing tissue damage from inflammation-
related enzymes. Superoxide dismutase 1 (sod1) is also regulated by Nfe2l2a, and is used 
to render superoxide inert by breaking down the molecules. The expression of these five 
genes were evaluated relative to beta-actin across a total of 11 time points from 0hpi to 
120hpi following injection of HBSS or infection from IAV. 
 Using the qRT-PCR results of relative expression, we can begin to theorize 
potential regulatory interactions among some of the genes. The most promising connection 
is between the ncf1 and nfe2l2a expression levels at 12 hpi. The expression of ncf1 was 
increased while the expression of nfe2l2a was decreased. NFe2l2a is a transcription factor 
that regulates the expression of antioxidant proteins which protect tissues from damage. 
ncf1 encodes a subunit of the Cybb complex that produces ROS. At 12 hpi, the transcription 
factor responsible for repressing the effect of ROS, nfe2l2a, is downregulated, while there 
is increased expression in a component of the NADPH oxidase complex. This inverse 
correlation suggests that at 12 hpi, there is an inverse correlation of expression of a gene 
enabling ROS containing molecules to be produced, and genes that needed to protect 
against ROS damage. 
 There is also a potential for inverse correlation between ncf1 and serpina1 at 18hpi. 
The Serpina1 protein also reduces tissue damage from inflammation. At 18hpi, ncf1 had 
decreased expression and serpina1 had increased expression. The inverse correlation 
between ncf1 and serpina1 at 18 hpi was opposite of what was observed with ncf1 and 
nfe2l2 at 12 hpi. In that relationship, ncf1 had increased expression and nfe2l2 had 
decreased expression. These two inverse correlations suggest that there is feedback 
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between the utilization of ROS by the innate immune system and genes that need to be 
expressed to limit damage to zebrafish tissues during the course of infection.  
 While the results from the qRT-PCR can be used to make some proposed regulatory 
interactions between the different genes associated with the respiratory burst response, 
there are some limitations of the experimental data. For one, qRT-PCR assays the RNA 
present in a sample, and not the protein levels. It is possible that the expression at the RNA 
level is completely different than that of the protein. Post translational regulation of 
proteins can also effect the actual amount of protein present at any one time. Furthermore, 
we assayed gene expression using RNA extracted from three whole embryos per sample. 
Three embryos were used to obtain enough RNA for the cDNA synthesis needed for the 
qRT-PCR assays. Each of the individual zebrafish may have had varying expression levels 
over the course of infection. This variation is lost by pooling the three embryos together. 
We also assayed RNA from whole embryos and not just phagocytes. Ideally, we want to 
understand the expression of these respiratory burst related genes in the context of 
neutrophils.  
 
Future Applications of the Tg(mpx:HyPer) Zebrafish Line: 
 Following its development, this zebrafish line will be a powerful tool for studying 
innate immunity in vivo. Zebrafish are used to study host-pathogen responses to bacterial, 
fungal and viral infection. At 4 dpf, localized infection of the swim bladder may be 
performed to study detect the levels of ROS associated with neutrophils in these host-
pathogen interactions. Furthermore, responses to injury can also be studied. We believe 
that the immunological responses observed in this model can be translated to humans.  
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 The ability to cross this line with other zebrafish lines will further research on innate 
immunity. Once developed, the Tg(mpx:HyPer) line can be crossed with various other 
zebrafish models to study additional immunological reactions to injury or infection. For 
example, this line could be crossed with the Tg(mpeg1:mCherry) line that expresses 
mCherry in macrophages. In another example, this model can be crossed with the WHIM 
(Tg1(-8mpx:cxcr4b-EGFP) model, that possesses defective neutrophils, to observe the 
change in the respiratory burst response with defective neutrophil trafficking.  
 The Tg(mpx:HyPer) model could be used to study the function of specific genes by 
knocking down genes using morpholinos. Morpholinos can be used to knockout a targeted 
gene over the first five days of development. Studies of morphants could reveal differences 
in H2O2 in response to infection. One gene of interest would be ncf1 as it has a known role 
in the respiratory burst response. New research by Lily Charpentier and Brandy Soos in 
the King Lab show that ncf1 morphants have increased survival following IAV infection. 
Knocking down ncf1 in the Tg(mpx:HyPer) model would allow us to visualize any changes 
in H2O2production in localized infection. 
 Following the development of this model, the respiratory burst response and the 
roles of reactive oxygen species may be further understood. This includes the many 
regulatory factors and feedback loops that are part of the innate immune response to injury 
or infection. Using this model, we may be able to test different small molecules that alter 
the ROS production during an IAV infection thereby optimizing the response to IAV. Any 
small molecules found could eventually become new treatments for IAV infection. For 
example, the drug Ebselen and other ebselen-sulfur analogs are known to inhibit Cybb 
(Sorce 2017). Cybb is the primary protein required for ROS production and inhibition of 
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Cybb would lead to a less robust respiratory burst response. Even though there may be a 
diminished response to IAV, it could stop a hyperinflammatory response that would 
otherwise lead to tissue damage. Similar small molecule screens could be performed to 
find new therapeutics for bacterial and fungal infections, and enhance responses to injury.  
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